How Bad Will the Flu Season Get? Forecasters Are Competing to Figure it Out

From analyses of surface protein evolution to tweets on social media, scientists are gathering all the data they can to accurately predict influenza dynamics.

Written byChristina Reed
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Transmission electron micrograph of an influenza virus particleWIKIMEDIA, CYNTHIA GOLDSMITH, CDC/DR. ERSKINE L. PALMER, DR. M.L. MARTINWith flu season upon us in the Northern Hemisphere, the perennial game of flu forecasting—the effort to provide real-time and forward-looking estimates of influenza cases—is underway. And each year, the Centers for Disease Control and Prevention (CDC) makes a competition of it, asking forecasting teams to come up with their best predictions for the timing, peak, and intensity of the season.

The CDC provides weekly surveillance data of confirmed flu and outpatient visits for influenza-like illnesses from public health and clinical laboratories around the nation. But these data lag behind real-time activity and not everyone who gets sick with the flu goes to the hospital. To advance flu forecasting efforts, the agency launched its first forecasting challenge during the 2013-2014 flu season with a first-place prize of $75,000. Since then, the monetary award has gone away, but teams have continued to participate for the honor of providing the most accurate forecast for the start of the flu season, how bad it will get over the course of the season, and when cases will peak.

For the last three flu seasons, Roni Rosenfeld’s team at Carnegie Mellon ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies